Aggregated price index with volume information
Summary:
- Medical Distributors stocks up 0.7% on average while median return up 0.1% in a day
- Medical Distributors stocks up 4.8% on average while median return up 2.8% in a week
- Medical Distributors stocks up 1.1% on average while median return up 1.7% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $HLF 15.7%, $OMI 10.7%, $PDCO 3.4%, $MCK 2.5%
- 1M losers are : Losers for past month are $HSIC -1.3%, $APLS -8.2%
- 1W winners are : Winners for past week are $ACET 15.2%, $HLF 10.3%, $OMI 6.2%, $APLS 3.8%
- 1W losers are : Losers for past week are $CAH -0.6%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 18.3%, for the past 3 months is 7.4%
In the past month for a 5 days rolling window, the highest corrrelation is 45.2%, the lowest correlation is 3.6%, the latest correlation is 24.1%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 66.2% between HSIC and PDCO
The lowest correlation is -56.2% between HLF and MCK
General Motors, Cardinal Health, Cencora, Alta Equipment Group and Asbury Automotive are part of the Zacks Screen of the Week article.
We believe that stocks like General Motors (GM), Cardinal Health (CAH), Cencora (COR), Alta Equipment (ALTG) and Asbury (ABG) should be on an investor's watchlist.
Mark Delong, Chief Business & Strategy Officer of Apellis Pharmaceuticals Inc (NASDAQ:APLS), has sold 9,913 shares of the company on March 18, 2024, according to a recent SEC filing.
REDWOOD CITY, Calif. & BOSTON, March 19, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial results and operational highlights for the fourth quarter and year ended December 31, 2023.
Product innovations and strategic progress bode well for Tandem Diabetes (TNDM).
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Revvity's (RVTY) next-generation newborn sequencing research workflow is likely to build the foundation for diagnosing rare diseases in the future.
Waters (WAT) launches Oasis WAX/GCB and GCB/WAX Cartridges for PFAS testing, thus boosting the Waters Operating segment.
High Tide (HITI) announces the acquisition of Queen of Bud to boost its in-house cannabis brand portfolio without burdening its significant capital expenditure.
Investors are optimistic about Chemed (CHE) on strong performance across the VITAS and Roto-Rooter segments.